CYTOMX THERAPEUTICS, INC.

AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN

Amended and Restated: March 19, 2025

Approved by Stockholders: June 11, 2025

(as Amended by the Board: March 18, 2026)

 

I.

INTRODUCTION

1.1 Purposes. This CytomX Therapeutics, Inc. Amended and Restated 2015 Equity Incentive Plan, as amended by the Board on March 18, 2026 (this “Plan”), is effective as of the date the stockholders of the Company approve this Plan. The purposes of this Plan are (i) to align the interests of the Company’s stockholders and the recipients of awards under this Plan by increasing the proprietary interest of such recipients in the Company’s growth and success, (ii) to advance the interests of the Company by attracting and retaining Non-Employee Directors, officers, employees and other service providers and (iii) to motivate such persons to act in the long-term best interests of the Company and its stockholders.

1.2 Certain Definitions.

…

CYTOMX THERAPEUTICS, INC.

AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN

Amended and Restated: June 11, 2025

(as Amended by the Board: March 18, 2026)

1. Purpose. The purpose of this Plan is to provide Employees of the Company and Participating Subsidiaries with an opportunity to purchase common stock of the Company through accumulated payroll deductions. It is the intention of the Company to have the Plan qualify as an “Employee Stock Purchase Plan” under Section 423 of the Code. The provisions of the Plan, accordingly, shall be construed so as to extend and limit participation in a manner consistent with the requirements of that Section of the Code. This Plan amends and restates the CytomX Therapeutics, Inc. Employee Stock Purchase Plan in its entirety, effective as of June 11, 2025.

2. Definitions. As used herein, the terms set forth below have the meanings assigned to them in this Section 2 and shall include the plural as well as the singular.

“1933 Act” means the Securities Act of 1933, as amended.

…

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this “Agreement”) is dated as of June 22, 2026, between Nexentis Technologies Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (including their respective successors and assigns, each a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective shelf registration statement under, and Section 4(a)(2) of, the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

…

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

PIPE COMMON WARRANT TO PURCHASE COMMON STOCK

NEXENTIS TECHNOLOGIES INC.

 

Warrant Shares: [●]

Initial Exercise Date: June 24, 2026

 

Issuance Date: June 24, 2026

…

FOREBEARANCE AGREEMENT

 

This Forbearance Agreement (this “Agreement”), dated June 16, 2026 (the “Effective Date”), is entered into by and between Algorhythm Holdings, Inc., a Delaware corporation (the “Company”), and SemiCab, Inc., a Delaware corporation (“Noteholder”). Capitalized terms not otherwise defined herein shall have the meaning ascribed to such terms in the Promissory Note (as defined below).

 

WITNESSETH:

 

WHEREAS, the Company and Noteholder are parties to that certain promissory note, dated May 2, 2025, in the principal amount of $1,750,000 (the “Promissory Note”); and

 

WHEREAS, under the terms of the Promissory Note, the Company was required to pay the Initial Payment Amount to Noteholder on May 2, 2026; and

 

WHEREAS, the Company failed to pay the Initial Payment Amount to Noteholder on May 2, 2026; and

 

WHEREAS, the Company and Noteholder wish to enter into this Agreement to waive any default or Event of Default that was or will be caused as a result of the Company’s failure to pay the Initial Payment Amount to Noteholder on May 2, 2026.

…

Document

Exhibit 10.1

Execution Version

 SHARE PURCHASE AGREEMENT

THIS SHARE PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of June 17, 2026, by and between BuzzFeed, Inc., a Delaware company (the “Company” or “Seller”), and Allen Family Digital, LLC, a California limited liability company (the “Purchaser”).

Recitals

WHEREAS, the Purchaser desires to purchase from the Seller, and the Seller desires to sell to the Purchaser, a total of four million (4,000,000) shares of the Company’s Class A common stock (the “Shares”), including 2,173,155 newly issued shares and 1,826,845 treasury shares, at a price of $1.44 per Share, on the terms and subject to the conditions set forth in this Agreement (the “Purchase”); and

…

Document

Exhibit 10.2

SHARE PURCHASE AGREEMENT

THIS SHARE PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of June 17, 2026, by and between BuzzFeed, Inc., a Delaware company (the “Company” or “Seller”), and _____________________ (the “Purchaser”).

Recitals

WHEREAS, the Purchaser desires to purchase from the Seller, and the Seller desires to sell to the Purchaser, a total of _________________________ newly-issued shares of the Company’s Class A common stock (the “Shares”), at a price of $1.44 per Share, on the terms and subject to the conditions set forth in this Agreement (the “Purchase”); and

WHEREAS, the audit committee of the board of directors of the Company (the “Board”) has determined that the Purchase is reasonable, and comparable to those that could be obtained in an arm’s-length transaction with an unrelated third party, is in the commercial interests of the Company, and has approved the execution, delivery and performance of this Agreement and the consummation of the Purchase.

…

EXECUTION COPY

FOURTH AMENDMENT

TO AMENDED AND RESTATED SENIOR SECURED CREDIT AGREEMENT

THIS FOURTH AMENDMENT TO AMENDED AND RESTATED SENIOR SECURED CREDIT AGREEMENT, dated as of June 16, 2026 (this “Amendment”), to the Existing Credit Agreement (capitalized terms used herein and not otherwise defined shall have the meanings given to such terms in Article I) is among BLUE OWL TECHNOLOGY FINANCE CORP., a Maryland corporation (the “Borrower”), solely with respect to Section 5.8 herein, the SUBSIDIARY GUARANTORS party hereto, the LENDERS party hereto, the ISSUING BANKS and SWINGLINE LENDERS party hereto and TRUIST BANK, as Administrative Agent (in such capacity, the “Administrative Agent”) and, solely with respect to Section 5.10 herein, as Collateral Agent (in such capacity, the “Collateral Agent”).

W I T N E S S E T H:

…

Exhibit 10.2

 

Execution Version

 

 

INCREASE AGREEMENT

INCREASE AGREEMENT, dated as of June 11, 2026 (this “Agreement”), to the Amended and Restated Credit Agreement, dated as of August 1, 2024 (as amended, supplemented or otherwise modified prior to giving effect to this Amendment, the “Existing Credit Agreement” and, as amended pursuant to this Amendment, the “Amended Credit Agreement”), by and among RIDGEPOST CAPITAL, INC., a Delaware corporation (f/k/a P10, INC.) (the “Parent”), RIDGEPOST CAPITAL, LLC, a Delaware limited liability company (f/k/a P10 INTERMEDIATE HOLDINGS LLC) (the “Borrower”), the Guarantors party thereto from time to time, the Lenders party thereto from time to time and JPMORGAN CHASE BANK, N.A., as administrative agent and collateral agent (in such capacity, the “Agent”), is entered into by and among the Borrower, the Parent, each other Loan Party, the Agent and the Additional Lender (as defined below). Capitalized terms used and not otherwise defined herein shall have the meanings assigned to them in the Existing Credit Agreement.

…

Document

Exhibit 10.1

EXECUTION VERSION

This TENTH AMENDMENT TO THE REVOLVING CREDIT AND SECURITY AGREEMENT (this “Amendment”), dated as of June 18, 2026 (the “Amendment Date”), is entered into by and among ARCC FB FUNDING LLC, a Delaware limited liability company, as the borrower (the “Borrower”), the LENDERS party to the Revolving Credit Agreement, BNP PARIBAS, as the administrative agent (the “Administrative Agent”), ARES CAPITAL CORPORATION, a Maryland corporation, as the equityholder (in such capacity, the “Equityholder”), ARES CAPITAL CORPORATION, a Maryland corporation, as the servicer (in such capacity, the “Servicer”), and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as successor in interest to U.S. Bank National Association, as collateral agent (the “Collateral Agent”).

…

Document

AMENDMENT NO. 6 TO TD SYNNEX CORPORATION

2020 STOCK INCENTIVE PLAN

In accordance with Section 21(b) of the TD SYNNEX Corporation 2020 Stock Incentive Plan (the “Plan”), the Plan is hereby amended as follows, effective as of June 17, 2026:

1.Section 4(b) is hereby amended and restated in its entirety as follows:

“4(b) Automatic Grants to Outside Directors.

(i)Each Outside Director who first joins the Board of Directors on or after the date of the Company’s 2026 annual meeting, and who was not previously an Employee, shall receive a number of whole Restricted Shares equal to the quotient of (x) $210,000 (or such other amount as may be determined under Section 4(b)(iii)), prorated for the number of months out of twelve that the Outside Director is expected to serve between the Outside Director’s appointment or election to the Board of Directors and the next regular annual meeting of the Company’s stockholders, rounded to the nearest month (y) divided by the Fair Market Value of a Share as of the grant date. For purposes of the calculation in the preceding sentence, any fr

…

CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

  

June 15, 2026

 

Dear Branislav:

 

In recognition of your contributions to HeartBeam, Inc. (the “Company”) and to provide additional incentives for you to maximize the value of the Company, the Company’s Compensation Committee of the board of directors (the “Board”) has awarded you a bonus opportunity (the “Transaction Bonus”) payable in the event of a Change in Control that occurs after the date first set forth above (the “Effective Date”), but prior to the Expiration Date (a “Qualifying Change in Control”), on the conditions set forth herein. Capitalized terms which are not otherwise defined in this agreement (this “Bonus Agreement”) have the meaning ascribed to such terms in Appendix A.

Transaction Bonus Amount and Conditions

…